| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MC.20632 |
| P8608 | Fatcat ID | release_a6jt3jf2kndv7ftgdv4txcfm6a |
| P698 | PubMed publication ID | 21465578 |
| P50 | author | Yasushi Yatabe | Q56697495 |
| P2093 | author name string | Takashi Takahashi | |
| Hidemi Goto | |||
| Motoshi Suzuki | |||
| Toshiyuki Takeuchi | |||
| Shuta Tomida | |||
| Chinatsu Arima | |||
| Yasushi Matsuyama | |||
| Ryoji Sugiyama | |||
| Yasutomo Itoh | |||
| Qin Miao Huang | |||
| P2860 | cites work | cDNA cloning and functional analysis of the p97 subunit of the 26S proteasome, a polypeptide identical to the type-1 tumor-necrosis-factor-receptor-associated protein-2/55.11 | Q24318067 |
| Large-scale cDNA transfection screening for genes related to cancer development and progression | Q24561958 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| Proteasome subunit Rpn1 binds ubiquitin-like protein domains | Q27930136 | ||
| Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1 | Q28235617 | ||
| Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach | Q28285607 | ||
| let-7 regulates Dicer expression and constitutes a negative feedback loop | Q28290736 | ||
| Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 | Q28294917 | ||
| The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism | Q29547302 | ||
| Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression | Q29615223 | ||
| A gene-expression signature to predict survival in breast cancer across independent data sets. | Q31057290 | ||
| Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis | Q31137292 | ||
| Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies | Q33345317 | ||
| A phase 2 study of bortezomib in relapsed, refractory myeloma | Q33348702 | ||
| Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis | Q34768131 | ||
| Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. | Q34963574 | ||
| The proteasome: a suitable antineoplastic target | Q35762448 | ||
| Intrinsic tumour suppression | Q35953133 | ||
| The proteasome: overview of structure and functions | Q36472495 | ||
| Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts | Q36639457 | ||
| Incorporating bortezomib into the treatment of lung cancer | Q36899925 | ||
| Signal integration by JNK and p38 MAPK pathways in cancer development | Q37560607 | ||
| Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. | Q38408304 | ||
| Structural features of the 26 S proteasome complex | Q39405119 | ||
| Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines. | Q40534906 | ||
| The targeting of the proteasomal regulatory subunit S2 by adenovirus E1A causes inhibition of proteasomal activity and increased p53 expression | Q40571413 | ||
| Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. | Q40902473 | ||
| Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. | Q46365315 | ||
| EGFR mutation is specific for terminal respiratory unit type adenocarcinoma | Q46439042 | ||
| Mts4, a non-ATPase subunit of the 26 S protease in fission yeast is essential for mitosis and interacts directly with the ATPase subunit Mts2. | Q48043731 | ||
| TTF-1 expression in pulmonary adenocarcinomas. | Q51716382 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 301-9 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Molecular Carcinogenesis | Q15724597 |
| P1476 | title | Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas | |
| P478 | volume | 50 |
| Q39186868 | 3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes. |
| Q36746536 | A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients |
| Q47326502 | ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT. |
| Q35141163 | An integrated approach of gene expression and DNA-methylation profiles of WNT signaling genes uncovers novel prognostic markers in acute myeloid leukemia. |
| Q52691004 | Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis. |
| Q90087490 | Cross-disease analysis identified novel common genes for both lung adenocarcinoma and lung squamous cell carcinoma |
| Q36471467 | Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC. |
| Q55350987 | Differential expression patterns of housekeeping genes increase diagnostic and prognostic value in lung cancer. |
| Q28246704 | Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours |
| Q54328862 | Genome-wide analysis of oral squamous cell carcinomas revealed over expression of ISG15, Nestin and WNT11. |
| Q38760910 | Identification of pathway-based prognostic gene signatures in patients with multiple myeloma |
| Q35076226 | Identification of reproducible gene expression signatures in lung adenocarcinoma. |
| Q41090797 | Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis. |
| Q33565864 | Integrative Analysis of Gene Networks and Their Application to Lung Adenocarcinoma Studies |
| Q90698035 | PEBP4 gene expression in lung squamous cell carcinoma: A meta-analysis-based study of the molecular pathways involved |
| Q64891425 | Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation. |
| Q28383695 | The expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohorts |
| Q37706211 | The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers |
| Q35826045 | The transition zone protein Rpgrip1l regulates proteasomal activity at the primary cilium |
| Q33292171 | UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells |
Search more.